Vincerx Pharma, Inc. Marketable Securities (Current)
Vincerx Pharma, Inc. had Marketable Securities (Current) of $7.14 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-11-12
- 2024-09-30: Marketable Securities, Current $7.14M.
- 2024-06-30: Marketable Securities, Current $8.40M.
- 2023-12-31: Marketable Securities, Current $0.00.
- 2023-09-30: Marketable Securities, Current $5.72M.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-09-30 | $7.14M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.40M 10-Q · filed 2024-08-08 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-12 |
| 2023-09-30 | $5.72M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.68M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $35.28M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $40.80M 10-K · filed 2024-03-29 |
| 2022-09-30 | $20.17M 10-Q · filed 2022-11-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-28 |